STERIS plc (NYSE:STE) Shares Purchased by Herold Advisors Inc.

Herold Advisors Inc. increased its stake in shares of STERIS plc (NYSE:STEGet Rating) by 29.7% in the 2nd quarter, HoldingsChannel reports. The firm owned 1,219 shares of the medical equipment provider’s stock after purchasing an additional 279 shares during the period. Herold Advisors Inc.’s holdings in STERIS were worth $251,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Trust Asset Management LLC grew its stake in STERIS by 5.4% during the 1st quarter. Trust Asset Management LLC now owns 956 shares of the medical equipment provider’s stock worth $231,000 after purchasing an additional 49 shares in the last quarter. Allworth Financial LP boosted its position in shares of STERIS by 11.8% during the 2nd quarter. Allworth Financial LP now owns 531 shares of the medical equipment provider’s stock worth $109,000 after acquiring an additional 56 shares in the last quarter. Siemens Fonds Invest GmbH boosted its position in shares of STERIS by 6.0% during the 1st quarter. Siemens Fonds Invest GmbH now owns 1,027 shares of the medical equipment provider’s stock worth $248,000 after acquiring an additional 58 shares in the last quarter. Values First Advisors Inc. boosted its position in shares of STERIS by 3.5% during the 1st quarter. Values First Advisors Inc. now owns 1,902 shares of the medical equipment provider’s stock worth $460,000 after acquiring an additional 64 shares in the last quarter. Finally, Private Advisor Group LLC boosted its position in shares of STERIS by 4.6% during the 2nd quarter. Private Advisor Group LLC now owns 1,486 shares of the medical equipment provider’s stock worth $306,000 after acquiring an additional 66 shares in the last quarter. 92.04% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

STE has been the subject of several research reports. Needham & Company LLC downgraded STERIS from a “buy” rating to a “hold” rating in a report on Friday. JMP Securities reduced their target price on STERIS from $270.00 to $250.00 in a report on Thursday, August 4th. KeyCorp reduced their target price on STERIS from $256.00 to $240.00 and set an “overweight” rating for the company in a report on Thursday, August 4th. StockNews.com raised STERIS from a “hold” rating to a “buy” rating in a report on Thursday, August 11th. Finally, Piper Sandler initiated coverage on STERIS in a report on Thursday, July 14th. They issued an “overweight” rating and a $240.00 target price for the company. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $252.00.

STERIS Stock Performance

STE traded down $9.47 on Friday, hitting $167.29. 2,465,836 shares of the company traded hands, compared to its average volume of 509,612. The stock has a market capitalization of $16.73 billion, a PE ratio of 45.13 and a beta of 0.75. The company has a 50 day moving average of $207.16 and a 200-day moving average of $218.80. STERIS plc has a 12-month low of $162.19 and a 12-month high of $255.93. The company has a quick ratio of 1.35, a current ratio of 2.03 and a debt-to-equity ratio of 0.44.

STERIS Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 23rd. Stockholders of record on Wednesday, September 7th will be paid a dividend of $0.47 per share. This represents a $1.88 dividend on an annualized basis and a dividend yield of 1.12%. This is an increase from STERIS’s previous quarterly dividend of $0.43. The ex-dividend date of this dividend is Tuesday, September 6th. STERIS’s dividend payout ratio is 50.40%.

STERIS Company Profile

(Get Rating)

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Featured Stories

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STEGet Rating).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.